NCT05764980 is a clinical trial of visual function evaluation in CHARGE Syndrome, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

Who is sponsoring NCT05764980?

NCT05764980 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS.

What drugs are being tested in NCT05764980?

Interventions in NCT05764980: visual function evaluation.

What condition does NCT05764980 study?

NCT05764980 studies CHARGE Syndrome.

Is NCT05764980 still recruiting?

NCT05764980 is currently status unknown. Last updated 13 March 2023.

Last reviewed 2023-03-13 · How we verify

NCT05764980

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neurovisual Function in CHARGE Syndrome

Status unknown Last updated 13 March 2023

What this trial tests

trial testing visual function evaluation in CHARGE Syndrome in 20 participants. Status unknown.

Timeline

15 March 2021

Primary endpoint
15 March 2023

1 January 2024

Quick facts

Lead sponsor	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	15 March 2021
Primary completion	15 March 2023
Estimated completion	1 January 2024
Sites	1 location across Italy

Drugs / interventions tested

visual function evaluation

Conditions studied

CHARGE Syndrome — all drugs for CHARGE Syndrome →

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 0 to 90, any sex, with CHARGE Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rationale of the study is to analyze visual function and correlate them with adaptive functions in patients with CHARGE syndrome in order to identify a pattern of specific indicators to enable better patient care

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for CHARGE Syndrome

Currently open trials in the same condition.

NCT04463316 — GROWing Up With Rare GENEtic Syndromes · recruiting

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05764980 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Last refreshed: 13 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05764980.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing